Thromboxane Receptor Antagonist to Improve Endothelial Function

NCT03962855 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Diseases
Vascular Dilation

Interventions

DRUG: Ifetroban Sodium
DRUG: Placebo

Sponsor

Jeffrey Rade

Collaborators

[object Object]
[object Object]